| Literature DB >> 6173316 |
D Serban, J M Pages, A E Bussard, I P Witz.
Abstract
Monoclonal IgM anti-erythrocyte autoantibody produced by a NZB-derived hybridoma has been found to react with trimethylammonium-containing compounds. Such compounds are able to prevent the lysis of bromelain-treated mouse erythrocytes (BrMRBC) by those autoantibodies. Using a column of insolubilized betaine hydrazine (BH) the monoclonal anti-erythrocyte antibody has been specifically retained. Elution of this antibody was accomplished by 0.15 M choline (Ch).Entities:
Mesh：
Substances：
Year: 1981 PMID： 6173316 DOI： 10.1016/0165-2478(81)90012-2
Source DB: PubMed Journal: Immunol Lett ISSN： 0165-2478 Impact factor: 3.685